- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 15, 2026 | 260.39M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 258.69M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 254.58M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$84.34K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$273.97K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$4.19M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$3.88M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | −$2.86M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$2.44M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $4.19M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $3.94M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $4.44M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $4.19M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $47.2K |
| Current Assets | Q1 2026 · Dec 31, 2025 | $105.39K |
| Total Assets | Q1 2026 · Mar 31, 2026 | $248.83K |
| Total Assets | Q1 2026 · Dec 31, 2025 | $316.7K |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.00 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.01 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $253.02K |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $1.37M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $12.56K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $116.25K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$315.84K |
| Net Income | Q1 2026 · Mar 31, 2025 | −$1.53M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$265.58K |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$1.49M |
| Revenue | Q1 2026 · Mar 31, 2026 | $0 |
| Revenue | Q1 2026 · Mar 31, 2025 | $0 |